These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 2451934)

  • 21. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological studies of human constitutive cyclooxygenase (COX-1) using enzyme immunometric assay.
    Créminon C; Frobert Y; Habib A; Maclouf J; Pradelles P; Grassi J
    Biochim Biophys Acta; 1995 Feb; 1254(3):333-40. PubMed ID: 7857974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases.
    Patrignani P; Panara MR; Greco A; Fusco O; Natoli C; Iacobelli S; Cipollone F; Ganci A; Créminon C; Maclouf J
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():129-31. PubMed ID: 7732817
    [No Abstract]   [Full Text] [Related]  

  • 24. Platelet cyclooxygenase expression in normal dogs.
    Thomason J; Lunsford K; Mullins K; Stokes J; Pinchuk L; Wills R; McLaughlin R; Langston C; Pruett S; Mackin A
    J Vet Intern Med; 2011; 25(5):1106-12. PubMed ID: 21985141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of platelet cyclooxygenase by red cells in vitro.
    Violi F; Ghiselli A; Alessandri C; Frattaroli S; Iuliano L; Balsano F
    N Engl J Med; 1985 Oct; 313(17):1091-2. PubMed ID: 3930963
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of platelet prostaglandin synthetase by oral aspirin.
    Burch JW; Stanford N; Majerus PW
    J Clin Invest; 1978 Feb; 61(2):314-9. PubMed ID: 413839
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoaffinity purification and cDNA cloning of human platelet prostaglandin endoperoxide synthase (cyclooxygenase).
    Takahashi Y; Ueda N; Yoshimoto T; Yamamoto S; Yokoyama C; Miyata A; Tanabe T; Fuse I; Hattori A; Shibata A
    Biochem Biophys Res Commun; 1992 Jan; 182(2):433-8. PubMed ID: 1734857
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose aspirin is a selective inhibitor of platelet cyclooxygenase activity in healthy subjects.
    Patrignani P; Filabozzi P; Patrono C
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():259-64. PubMed ID: 6221533
    [No Abstract]   [Full Text] [Related]  

  • 29. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases.
    Buccellati C; Sala A; Ballerio R; Bianchib M
    Eur J Pain; 2000; 4(4):413-5. PubMed ID: 11124014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ibuprofen enantiomers and its coenzyme A thioesters on human prostaglandin endoperoxide synthases.
    Neupert W; Brugger R; Euchenhofer C; Brune K; Geisslinger G
    Br J Pharmacol; 1997 Oct; 122(3):487-92. PubMed ID: 9351505
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arachidonic acid metabolism in the neonatal platelet.
    Stuart MJ; Allen JB
    Pediatrics; 1982 Jun; 69(6):714-8. PubMed ID: 6804924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of platelet cyclooxygenase by aspirin-like drugs: methods for in vitro and ex vivo assessment.
    Patrono C; Ciabattoni G; Pugliese F; Pinca E; Castrucci G; De Salvo A; Satta MA; Parachini M
    Agents Actions Suppl; 1979; (4):138-46. PubMed ID: 115255
    [No Abstract]   [Full Text] [Related]  

  • 33. Do human platelets express COX-2?
    Reiter R; Resch U; Sinzinger H
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jun; 64(6):299-305. PubMed ID: 11427038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genetic defects of prostaglandin and thromboxane synthesis].
    Schrör K
    Wien Klin Wochenschr; 1985 Jan; 97(2):64-70. PubMed ID: 3920834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent inhibition of platelet cyclooxygenase-1 and monocyte cyclooxygenase-2 by meloxicam in healthy subjects.
    Panara MR; Renda G; Sciulli MG; Santini G; Di Giamberardino M; Rotondo MT; Tacconelli S; Seta F; Patrono C; Patrignani P
    J Pharmacol Exp Ther; 1999 Jul; 290(1):276-80. PubMed ID: 10381787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-dose enteric-coated aspirin: a practical approach to continuous-release low-dose aspirin and presystemic acetylation of human platelet cyclooxygenase.
    Jakubowski JA; Stampfer MJ; Vaillancourt R; Faigel D; Deykin D
    J Lab Clin Med; 1986 Dec; 108(6):616-21. PubMed ID: 3097223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Mechanism of changes in the platelet functional activity caused by low energy laser irradiation].
    Spasov AA; Nedogoda VV; Konan K
    Biull Eksp Biol Med; 1998 Jul; 126(7):45-8. PubMed ID: 9777195
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.